pharmaceutically acceptable emulsions solutions suspensions syrups and elixirs in addition to the active compounds the liquid dosage forms may contain inert diluents commonly used in the art such as water or other solvents solubilizing agents and emulsifiers as for example ethyl alcohol isopropyl alcohol ethyl carbonate ethyl acetate benzyl alcohol benzyl alcohol benzyl benzoate propyleneglycol 1 3 butyleneglycol dimethylformamide oils in particular cottonseed oil groundnut oil corn germ oil olive oil castor oil and sesame oil glycerol tetrahydrofurfuryl alcohol polyethyleneglycols and fatty acid esters of sorbitan or mixtures of these substances and the like besides such inert diluents the composition can also include adjuvants such as wetting agents emulsifying and suspending agents sweetening flavoring and perfuming agents suspensions in addition to the active compounds may contain suspending agents as for example ethoxylated isostearyl alcohols polyoxyethylene sorbitol and sorbitan esters microcrystalline cellulose aluminum metahydroxide bentonite agar agar and tragacanth or mixtures of these substances and the like since the effect of the secretory iga antibody is dependent on its reaching the small intestine preferred tablets or capsules are enteric coated alternatively the active secretory iga antibodies can themselves be microencapsulated prior to formulation preparation of microcapsules of secretory iga antibody as well as preparation of enteric coated tablets or capsules can be achieved by conventional methods as detailed above the amount of an iga effective to treatment symptoms of celiac disease is appreciated to be dependent on the form and route of administration as well.